Archived Facts

(Reuters) – Abbott Laboratories Inc said its partner Reata Pharmaceuticals was discontinuing a late-stage trial of their kidney disease drug based on safety concerns raised by an independent safety committee.

Popular Posts:

Related Posts:

Leave a Reply